Form 4 for PFE Pfizer
Accepted 2022-04-01 00:00:00 ET · period of report 2022-03-31 · accession 0001225208-22-005294 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-01 | 2022-03-31 | PFE | Pao William | EVP | A - Grant | $0.00 | +115.9K | 115.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-31 | A | A | 115,897 | $0.00 | 115,897 | D | — | — | (F1) The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. |